Skip to main content
  • Explore a Treatment Option
  • About MIND-TD
  • Explore a Treatment Option
  • About MIND-TD
Site logo

The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.

  • Home
  • Symptoms of TD
    • Screening & Diagnosis
    • Differential Diagnosis
  • TD Treatment
  • Library
  • Explore a Treatment Option
  • About MIND-TD
  • Explore a Treatment Option
  • About MIND-TD
Back to the Library

Risk Factors for Tardive Dyskinesia—Is My Patient at Higher Risk?

  • Stuart Isaacson, MD

Presentation

•

~2 mins

•

Oct 2022

Download
Copy Link Share via Email Share via SMS
1

1 of 6

Related Resources


  • Podcast

    •

    ~10 mins

    •

    Dec 2024


    Screening for Tardive Dyskinesia: Best Practices in Person, Over Video, or via Telephone
  • Presentation

    •

    ~2 mins

    •

    Oct 2022


    Guidelines and Consensus on Screening and Treatment of Tardive Dyskinesia
  • Video

    •

    ~3 mins

    •

    Nov 2022


    Expert Commentary: Differentiate Tardive Dyskinesia
Neurocrine Biosciences Logo

©2025 Neurocrine Biosciences, Inc. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
  • Accessibility
  • Site Map

CP-TD-US-1751 04/25

The MIND-TD website and educational content were sponsored and co-developed by Neurocrine Biosciences, Inc. The faculty have been compensated by Neurocrine Biosciences. This non-CME program is intended to provide general information about tardive dyskinesia and not medical advice for any particular patient.

You are about to leave this website

Leave Site

By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.

This site contains information intended only for US healthcare professionals involved in the management of people with tardive dyskinesia.

This website is part of a disease-awareness, non-CME program sponsored by Neurocrine Biosciences, Inc.